Podcast: Under the microscope – Medlab Clinical (ASX:MDC), Dr. Sean Hall, CEO and MD. By Iain Wilkie 17 November 2020, 11:00 AM Morgans analyst Iain Wilkie chats to Dr Sean Hall who is the CEO and MD of drug development company Medlab Clinical (ASX:MDC) on some recent news and upcoming catalysts. Read more...
Under the Microscope: Key catalysts for October 2020 By Scott Power 27 October 2020, 12:05 PM Short-term trading opportunities in the Healthcare sector Read more...
Healthcare - Overall: At a political crossroads into US election By Dr Derek Jellinek 29 October 2020, 12:00 AM In this note, we assess the impact across key healthcare segments, highlighting ASX and international listed companies as well as ETFs which allow exposure to these themes. Read more...
Covid-19 Vaccine – Where are they now? By Dr Derek Jellinek 13 October 2020, 4:45 PM Morgans Senior Analyst, Dr. Derek Jellinek, provides a comprehensive update on the Covid-19 Vaccine. Additionally, Derek breaks down the key stakeholders within the race, and how they are currently positioned. Read more...
CSL: Donors need not a flip of a switch By Dr Derek Jellinek 20 August 2020, 4:00 PM We adjust FY21-22 estimates and roll forward our valuation multiples, with our price target increasing. Read more...
Cochlear: Its deafening – new pt starts and clinic capacity By Dr Derek Jellinek 19 August 2020, 11:00 AM FY20 results were negatively impacted by COVID-19 deferral of elective surgeries, with sales declining across all divisions, margins contracting, underlying profit falling by double-digits and the dividend remaining suspended. As a result, we have asjusted our FY21-22 expectations. Read more...
Reporting Season Preview: Healthcare Sector By Dr Derek Jellinek 27 July 2020, 10:30 AM Morgans Senior Analysts Derek Jellinek and Scott Power share a preview of the healthcare sector ahead of the August 2020 reporting season. Read more...
COVID-19: Pathway to a vaccine By Dr Derek Jellinek 23 July 2020, 2:50 PM Executives from five drug companies leading the COVID-19 vaccine race (ie AstraZeneca (LON; AZN), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE)) appeared in front of the US House Energy and Commerce Oversight and Investigations Subcommittee to talk about their progress in developing a product the entire world desperately needs. Read more...
Podcast: Morgans Conversation - Ron Weinberger, CEO of EMvision (ASX:EMV) By Chris Titley 11 June 2020, 8:23 AM I chat with Dr Ron Weinberger, Chief Executive Officer for EMVision (ASX: EMV) about the progress the company is making with their medical imaging technology to assist with stroke diagnosis. Read more...
Podcast: Healthcare sector update By Scott Power 12 May 2020, 12:45 PM I outline our preferred healthcare exposures, discuss Cochlear’s recent trading update and flag telehealth as a structural shift occurring in the industry. Read more...